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Pemphigus vulgaris is an autoinunune bullous disorder 
characterized by autoantibodies directed against 
d esmoglein 3. A group of19 pemphigus vulgaris sera were 
characterized by itntnunoblotting, i1n1nunofluorescence, 
inununoprecipitation, and the passive transfer mouse 
1nodel. The aim of these studies was to detennine the 
specificity of the autoantibody response in these patients. 
All patients had clinical and histologic evidence of pem-
phigus vulgaris. Fogo selvagem sera (n = 8), bullous 
pemphigoid sera (n = 8), antinuclear antibodies positive 
sera from patients with lupus erythematosus (n = 2), and 
nonnal hutnan sera (n = 8) were used as controls. 
All pemphigus vulgaris patients showed titers of IgG 
autoantibodies by indirect imtnunofluorescence ;;. 1 :160, 
predominantly of the IgG4 subclass and immunoprecipi-
tated recombinant destnoglein 3 expressed in the baculo-
virus system. Patients with disease localized to the 
mucous metnbranes showed no reactivity with desmo-
P emphigus cncomp:.tsses a gro up of auto im m une blistering d iseases, in w htch pa thogenic autoa n tibodies dir ec ted aga inst the ke ratinocyte ce ll sm face lead to in traepide rmal acantho lysis and blister fo rmation (Lever 1953; Beutner and J o rdo n, '1964). Pemphigus vulga ri s (PV) is characteri zed 
by mu cosa l as weiJ as skin lesio ns and aca nth olys is that occurs in the 
suprabasilar b yer. T he mu co us m embranes se rve as the initial site of 
in volvemen t of PV in up .to two-thirds of pati ents (M eurer ct nl, '1977; 
13eckc r and Gaspari, 1993). T he disease may remain localized to the 
mu co us mem branes, o r in most cases, progresses to in volve the glabro us 
ski n . In contras t, mu cosa l in volvem ent is absent in pemphi gus foliaceus 
(Riv itti ct nl, '1994) . T he p;tthogenic ro le o f PV au toan tibodies has 
been con fi rm ed by the in d uctio n of aca nth o lys is in skin o rga n cultures 
w ith PV lgG (Schil tz and Mi che l, '1976, 1979) and th e successful 
ind uctio n of PV in neonata l mice by passive transfer experim ents 
(An halt ct nl, 1982, 1 986). 
T he epi de rm al anti gen recogni zed by PV autoan tibodi es has been 
identifi ed as a 130-kDa glycopro tein that is immun o precipitated fi·o m 
ke rat in ocyte ex tracts as pa rt of th t! " PV co m plex" (Sta nl ey cr nl, 1982, 
1984; Eyre cr a/, 1987), w hi ch also in cl udes the 85-kDa mo lecul e 
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glein 1 and only one had weak reactivity with mouse skin 
by indirect immunofluorescence (titer = 1:20). Sera of 
four of these n1ucosal patients were tested in the 1nouse 
rnodel and three of four did not elicit skin or mucosal 
disease in the anin1als. In contrast, sera fron1 all seven 
patients with disease involving the skin and mucous 
membranes (generalized disease) produced disease in 
neonatal mice. In one patient the disease evolved from 
pure 1nucosal involvetnent associated with anti-desmo-
glein 3 antibodies to a disorder involving 1nucosas and 
skin . This transition was associated with the appearance 
of anti-desn1oglein 1 antibodies in the patient's serun1. 
These studies indicate that the autoantibody response in 
pen1phigus vulgaris is heterogeneous. Epitopes recog-
nized by some pemphigus vulgaris sera are species specific 
and others tnay be n1ucosal specific . ICeJ' 111ords: baculol!il'llsl 
/milo us disease/ desm.ogleiu/ epidermis. ] l11.11est D emwtol 
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plakoglo bin (l{ornu n cl n/, 1989). T he eDNA encoding the PV antigen 
has been cloned :md sequ enced , identi fYin g the an tigen as desmogle in 
3 (Dsg 3), a desm osomal glycopro tein that belo ngs to th e cad herin 
fa mi ly of calcium- depend ent ce ll adh es io n mo lecul es (Amagai cl nl, 
'1991). Affini ty purifi ed Dsg 3 antibodies fro m patients' se ra w ill also 
indu ce suprabasilar acanth o lysis in neonatal mo use sk in (Ant aga i ct nl, 
'.1 992), and th e pathogenici ty o f pa tients' st: ra ca n be abrogated by 
preabsoq.J tio n w ith recombinant Dsg 3 (Am aga i et nl, '1994; M emar 
ct nl, 1996), pro viding furth er evidence that autoa ntibodi es ;tga inst Dsg 
3 are th e compo nen t o f patie nts' sera th at ca use aca nth o lys is in the 
skin . Auta<mtibodi es to the t:Xtrace llular do maim of Dsg 3 may d irectl y 
impair cell adh es io n o r may tri gger intracellular signalling that mediates 
acan tho lysis (Seishim a ct nl, 199S; Esa ki et a/, 1995). 
Cad herins are tra nsmembrane glycopro teins that med iate cell-ceLl 
adh es io n in a calcium-depende nt manne r thro ugh ho mophili c inter-
acti o ns of th eir ex tracellula r domain (Rin gwa ld ct nl, 1987; Ta ki echi , 
'1987). Within the ca dh erin [ nnil y, Dsg 3 shares the hig hest sequ ence 
ho m ology w ith Dsg l , th e target anti gen recogni zed by pemphig us 
fo liaceus (PF) autoa n tibodies. Interes tin gly, Dsg 1 is recognized by 
=5Q'J1, of PV sera (Eyre and Stanley, J 987; Em ery ct a/, '1995 , Am aga i 
ct a/, '1996); however, th e pathogenic relevance of these :111 ti-Dsg 1 
au toan tibodies in PV is unknown . Th e purpose of this stu dy was to 
evaluate th e clini ca l presen tatio n as weLl as the tissue and species 
specificity of tb e autoantibody respo nse in PV se ra . O ur studi t:s clearl y 
dem onstrate th at PV pati ents ex hibit a heterogeneous au toa ntibody 
respo nse, w hi ch in so me cases is tissue and sp ecies specifi c. 
MATE r~ I A LS AND METH O DS 
Sources of human sera and tissue A panel of 1 'J well -characterized I' V 
sera we re utili zed fo r thes.; stud ies. T he sera was d rawn fi·o m patients with th e 
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cl inica l ond histologic diagnosis of i'V. All I'V patients hJd positive di rect 
immunofluo rescence (I F) :mel indirect IF titers against lllonkey esophagus 
:;, I: I GO. C li11i ca ll y, five of these pati ents hod mucosa l diseast: only at the ti 111 e 
t he ir se rum was d raw n. :md 14 h:1 d gcn t: r;"~ l i zcd disease in vo lving both the skin 
and the mucous 111 embranes. f the fi ve lllllcosal PV patients, fo ur had disease 
restri cted to the oral mucosa, ond one patient also had vul vo r and esophogeol 
in vo lve m e n t . Contro l SL'rJ inclu tlcd e nde mi c PF (Fogo sdvage m) patiL'nts (n = 
8). 11ormal vo lunteers (n = 8), a11tinuelea r antibodies positi ve sera (11 = 2), a11 d 
bu ll ous pemphigoid patients (n = 8). l' resh nonnol ht1111 an skill wJS co ll ected 
fi·om plas ti c surge ry procedures . Li kew ise, no rm :1 l bucc:1l rnucQsa \V~t s o b tai ned 
fro111 o ral surgL' ry procedures . 
Determination of autoantibody subclass reactivity by indi rect IF Anti-
ep idermal autoantibodies were dt:tected by indirec t IF using cryosecti o 11s of 
rnonk ~.:y oesophagus, human skin , hu m an bucca l mucosa, o r lllO LISt' ep ide rmis 
and flu oresce i11 isothiocyana te-conjuga ted goat ami- human lgG as previously 
reported (Matis ct nl, 1987). Subclass reactivity was detcrmi m•d utili zing 
lllonoclo 11al antibodies to individual human lg subclasses (R ock cr nl, 1989). 
All b u l1~rs were calcium supplemented. 
Detection of anti-Dsg 3 autoantibodies by immunoblott.ing (JB) 
procedures Ep ide rmis and but:cll 111ucnsa were ex tr:Kte i in Zt.X'1 sod iu111 
dodccyl sul f.1 re (S DS) co ntoini11g 0.06 M Tris. 5'Y.> b-mecaptoe thono l, I llllllol 
dithiothreitol per li ter, ·1 mmol eth ylencglycol-bisQ-a minoethyl ether)-
N ,N,N ', N ' - tctr:t ~l cet i c ac id per liter. The extracts were also trea ted with 
0. 1 lllll lol phenylmt: th ylsulfonyl Au o ride pn liter, and Ill f.lg pe r ml of each of 
the prort:ase inhibito rs pepstatin, antipain, leupepti 11 , and chymostatin. The 
protei 11 <:x troc t was separa tL'd d ectrophoreti cally by 7.5% SDS-polyacl")' lamide 
gel electropho resis (PA GE) and subsequently transferred to a nitrocellulose 
nwmbranc. The lli trocdlulosc paper was i11 cubated with a PV 011d control sera 
and the u11bo und antibodies were removed by sevt:rol wash steps as descri bed 
elsewhere (Calva nico ct 11/, 1991 ). The nwmbr:111 e was then incubated with 
ho rseradish peroxidase-labeled all ti- lllllll :lll lgG4 anti bodit:s, and the prote in 
bands were visualized by chemilumillesce ll cc (E L kit, Amersha111 , U.K .). 
Expression of the extracellular domain of Dsg 3 in the baculovirus 
system and immunoprecipitation (JP) procedures The extracd lular 
du J11 ;1in of I sg 3 \~'aS clo ned and expressed usin g the b:Kul ov irus sys tem 
(MaxBac BEVS, In Vitrogen. San Diego, A). Uti li zing the published eDNA 
sequence o f ht11na11 Dsg 3 (Amagoi et ,i/, I 991 ). the Dsg 3 extroce llular domain 
(ind udi11 g its sig11a l sequence) was polymerase chai 11 reaction (PC 11..) ampli fied 
in threL' segmt: nts from a keratinocyte eDNA libr:11-y. The three cDNAs were 
lig:ued in tht: PC R II vecto r and, to emble expression in the baculovirus 
system, ;1 Koza k ·cquence \Vas added in ti·onr of t he trans btio n initiation sitl'. 
T he insert was i'Ld ly sequenced and proved to be identi ca l with the published 
Dsg 3 sequence. The cl NA was cloned into the bac ulovirus expression vecto r 
i'VL 1393 and co transfected with wild-type boculovirus genome into Sfl) insect 
ce ll s. Recombinant virus was iso lated by li 11 1i ting dilution , and putative 
bac ulovirus recombinants were a1tdysed by PC I'l.. to i11sure that no wi ld- type 
virus remain ed. The titer of tht: vira l stock was determined to be 10 111 pfu per 
mi. Fo r prott: in producti on .I 0 multiplicity o f infec ti on of virus were added to 
high-S insec t cells (In vitrogen, Sa n Diego, CA) and the culture medium was 
harvested at 72-h interva ls. As the recombinants conta ined the Dsg 3 signal 
seq ue nce and ex t racellu la r d o main. but not the trans m e mbr:1n e o r intracellul ar 
do ll1ai 11 , th e cxpresst:d protein was sec reted into th t: culture medium. 1..ecombin-
anr D sg 3 (rDsg 3) was iodina wd usi11 g ·hlora mine-T as previously done in 
o ur labo ratori es (Ca lv:mico et nl, 199 1) and i11 cubated with PV a11d comrol 
sera, and th e.! solu bl e immune cotnpl cxe.s \ Vl'l't! bo und to Stnp/Jylomcclls tl lii'C'HS 
cd ls co 11taining staph ylococca l protei II A in the presence of ca lcium (Ob gue-
Aico la et a/, I 'J94). The bo u11d lgG and :mtigen were el uted with I X SDS 
sa mple; bufl~ r (0.5 M Tris HCI, pH n.8, 2% SDS, 5% P-mercaptoethanol) one! 
then ana lyzed by SDS- PAGE usi11 g '10% gels under reducing conditions. The 
ge ls we rt: dri ed and analysed by autoradiograph y. 
Testing PV sera for Dsg 1 reactivity R eactivity of PV sera with Dsg I 
was dctermi11 ed by I B and I P procedures. IL3 W :JS performed utilizing ex tr<~ c ts 
of normal hum:m t:p idennis in the same manner as described fo r Dsg 3. T he 
IP assays were IJerfo rmed using the pa rtiall y purified 125 1- labdecl 45-kDa Dsg 
1 fi·agmcnt from an ex tract of bovine snout ep idermis fo llowing procedures 
previously described (Ob gue-Aica la ct nl. 199+). UrieAy, the 1251- labded 
45-kDa Dsg I fragn1 ent was incubated with i'V and comrol sera fo r 1 h at 
room te mperaturt·. Fixed S. wllt' IIS ce lls were used to bind the illu1lune 
complexes as desc ribed above and ext racted with 0.2 M glycin t:/ 1-1 I pH 2.8 
CO il toi ning 5 mM ethyknediaminc tetraace ti c ocid and analysed by one-
dimensional 10% SDS- PAGE. The released [Jrotei ns were analysed by autorad io" 
graph y. 
Fu ll length 11uma11 Dsg I was cloned from a human kerat i11 ocyte eDNA 
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library and shown by sequence analysis to be identical to the previously reported 
sequence of Dsg I ( .oodwin 1'1 a/. 1990). The Dsg I insert was subcloned into 
the eub ryo ti c expression vector, pSV L, and expressed on the surf.1ce of COS-
1 ce lls. Express ion of recombinant Dsg I (rDsg I) on the surf.1ce of COS- I 
ce lls was desc ribed in detai l elsewhere (EnlCly ,., nl, I 995). Viable COS/ Dsg I 
transfectants were a11Ji ysed by indirect IF for reactivity with PV and control 
se ra usi ng TUS Co++ (10 mM Tris, pH 7.5, ISO mM NaCI, I m/\11 ea lcit11n , 
and 10% ft:t:d bovi ne serum). 
Testing of pathogenicity in the passive transfer anitnal model lgG 
fracri ons were prepared fro m PV sera and controls by 50% ammonitllll sul f.1tc 
prec ipitation, fo ll owed by ge l fi ltration chro matography utili zing Sephadcx G-
200 equi librated with phosp h o te-butl-~rcd sa line, pH 7.2 (A nhalt 1'1 a/, 1982; 
Anha lt ct 11/, 1986). Te11 milligrams per grnm body we ight of fi lter-sterilized 
lgG w:ls inj ected subcutJneously into neo n:.t tal BALB/c mi ce litrcnn:ues twi ce 
dai ly using 50 ~ll of lgG solution per injection. After 2+ h, the animals were 
sac rifi ced and sen1111 and skin stnn ples \vcrc obta ined for henlatO)..'-y ljn and L"Osi n 
staining and IF procedures. In additio n, sa mples o f the to ngue and buccol 
mucosa we re also analysed by histologic examination and direct I.F assays. 
R ESULTS 
Characterization ofPV sera by indirect IF As shown in Table I , 
all PV poti ents had c irculatin g lgG autoantibod ies"" I :1 60, by indirect 
IF using m o nkey oesophagus as substrate, lgG4 w as the predomin :mt 
subcb ss ("19 of 19) ; the lgG4 m ed ian tite r wos I :640 (range 1: 160-
1 :1280). lgG l autoantibod ies were present in 11 of 19 pati ents; th ose 
that were pos iti ve had a m edian tite r o f I :40 (range ·1 :20- 1 :320) . In 
e ight of 19 patients there were low titers of lgG2 autoantibodies (1 :20). 
Low titers of lgG3 antibodi es ( I :20) were detected in two pa tients. 
No difieren ces in subclass reac tiviry were detected b e tween the pati en ts 
w ith mu cosa l PV and th ose w ith gen eralized in vo lvem ent. Of the '19 
P V sero tested, 12 showed PV au toamibody tite rs that were re morkab.l y 
lower o n m o use skin than th ose o btain ed on m o nkey oesophagus 
(Table 1). A gain , lgG 4 was the predo min ant lgG subclass (range I :20-
1 :320). Four of the patients w ith mu cosal PV fai led to react with 
m o use skin. A fifth patiem w ith mu cosa l PV showed o nl y a low titer 
of lgG 4 autoantibodies (1 :20). 
Th e indirec t IF tite rs of th e PV sera were also tested and compared 
o n human skin and bu cca l mu cosa as substrates (Table I) . Fo ur pa tients 
w ith mu cosa l PV sh owed higher tite rs o n mucosa than o n epidermis. 
and the fifth patie nt with mu cosa l PV had equal tite rs o n ski n and 
mucosa . T h e PV ;llltoa nti body tite rs of the StT a of 14 re m aining 
pati ents w ith gen eralized disease showed the fo Ll owing results: in e ight 
patients the tite rs were hi gh er o n lllu cosa l substra te, in three patients 
th ese tite rs were similar in b o th substrates, and in three pati ents the 
tite rs were higher o n skin substrate . 
Mucosal PV patients recognize Dsg 3 but do not cross-react 
with Dsg 1 As shown in Table I , in 11 of 19 of the PV patie nts 
th e re was reacti vity w ith a 130-kDa peptide fi·o m n orm al human skin 
by I B. In add iti o n , six of ·19 sera sh owed reac ti vity w ith a 160-kDa · 
peptide that comigrared with D sg I and this reactivity could be 
abroga ted by preobsorpt io n wi th b ovine Dsg 1 fra gm en ts (data n o t 
shown). A ll six of these pati e nts had gene rali zed d isease. 
Figure 1 shows an 1B of cu.ltu re supernatant con tain ing the expressed 
67-kDa peptide, th e expec ted size of th e recombin ant ex tracellular 
domain of Dsg 3 . By IB , the expressed peptide was also recognized 
by PV sera and rabbit anti-Dsg 3, but not by no rma.! human se ra. 125 1-
bbeled rDsg 3 produced by the bacul ovirus was immunoprecipitared 
by all 19 PV se ra (Fig 2), ln contrast normal human se ra (n = · ) , 
bu ll o us pemphigoid (n 8) , PF (n = 8), o r lupus sera (a ntinu clea r 
antibodi es positi ve, n = 2) did not immunoprecipitate th e rDsg 
3 protein. 
Utili zing IP, nine of l9 of th e PV sera could inunun o precipita te th e 
bovine 45-kDa D sg 1 ti:agm enr (Table I) . Wh e n rDsg I was expressed 
o n th e surhtce of COS cell s, reac tivity could be detected by indirec t 
IF in o ne Jddi tional patie nt (Patient ·1 0), All L1.ine of th e p:~tients w h o 
were pos itive by I P wi th th e bovin e .I sg I fi·agm e nt were also reactive 
w ith D sg 'I expressed o n CO ce lls, T h e use of these three m e tho ds 
showed that l O of 19 PV se ra reacted with D sg 1 by at least o n e 
techniqu e . In terestingly, th e fi ve pa ti ents w ith di seose restri c ted to th e 
mu cosae sh owed no Dsg 'I cross- reJctivity by any of these m eth ods, 
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Table I. The tissue a nd species specificity of PV autoantibodies b y differe nt assays 
P3tient PV type Hum3n tissues'' Monkey esophagus/> Mouse skin' Epi-cxt" rDsg" Uov. Dsg 1/ rDsg 1-COS~ Mo use model'' 
Skin Mucos;t lgG 'I lgG2 lgG3 lgG4 lgG 1 lgG2 lgG3 JgG4 
Mucos31 1:160 1:1 280 'I :640 130 + ncg(S/8) 2 Mucos31 1:160 1:320 1:320 130 + neg( I'J/ 19) 
3 Mucos31 1:320 I :640 1:140 1:1 20- 1:640 130 + neg(5/5) 4 Mucos31 '1:1 60 I :320 I :1 40 1: 120- 1:640 130 + N D 5 Mucos31 1:320 1:320 1:640 '1:20 + pos(6/6) 6 Gener3lizcd 1:320 I :1280 1:320 1:20 130 + + + ND 7 Gencr3lized 1:80 1:80 1:20 1:160 130 + ND 8 Gener3lizcd I :320 1:320 'I :1280 1:40 130 + + + ND 9 Gcncr31i zed '1:320 1:1 280 1:320 '1:20 1:20 1:640 1:40 + + + N D 10 Generali zed 1:1 60 '1:160 1:20 I :640 1:20 1:320 + + pos(5/5) 11 Generalized 1:160 1:80 1:320 + ND 12 Generalized ., :640 I :320 1:80 1:320 + N D 
13 Gener31i zcd 1:320 1:640 ·1 :320 1:20 1:160 130,160 + + + ND 14 Gencdized 1:160 1:320 1:40 1:20 1:20 1:1280 1:40 1:320 130, 160 + + + pos(2/2) IS Gen erali zed 'I :640 '1:51 20 1:80 1:20- I :640 1:80 I :20 1:80 '130, 160 + + + pos(4/4) 16 Generalized ·1 :640 1:1280 'I :40 1:20- 1:160 1:40 1:20 1:320 160 + + + pos* 17 Generalized I :640 1: 160 1:80 '1:20- I :1280 1:40 + pos(24/24) 18 Generali zed ·1 :640 1:1280 1: 1280 1:1 60 160 + + + pos* 19 Generalized I :640 1:2560 I :20 '1:20- 1:1 280 '1:20 1:320 160 + + + pos(4/4) 
" ln d ircn 11= usi 11g hum:111 tissue substrn tcs :~ n d mo noclonal anribo dies aga inst human lgG ...J . 
b ln d in;c t 11: using m o nkey csoph:tgus substra te. 
' lndi n.:ct IF using mo use ski n substra te :m d lll Onoclonal ant ibod ies :-.g:1 inst ln un:m lgG subclasses. 
•
1 lmJJHJnoblotting utilizing hu 111 :1 11 cpidcn n:. I 1.'Xtrac ts. 
c lm Jnunoprccipi tation usi ng rad iolabcled Dsg 3 prod uced in the.: baculovirus syst t-: 111 . 
.f lm lllllllOprccipit:nio n using th e 45-kDa bovine (Bov.) Dsg I inmwnon..::~crivc fragment. 
.~ lndirc:c t IF usi ng rDsg 1 expressed 0 11 the su rf.1cc of COS cells. 
1
' Neon :n:-~ 1 mice were injc:crccl subcutnncously wi th test lgG (i·:~c tion s. ND, no r determi ned. 
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Figure 1. Anti-Dsg 3 antibody reacts with the recombinant extracellular. 
domain of Dsg 3 expressed in the baculovirus system . l'eptides in the. 
culture supernatant fi·01n high-S insect cells expressing the recombinant protein 
were separated by SDS-PAGE 3nd immunobloned with rabbit anti - Dsg 3 (lnue 
1) or preinunune rabbit seru m (laue 2). Anti- Dsg 3 antibodies recogni ze a 
peptide of 67 kDa. the pred icted size of the ex tr3cellul3r domain of Dsg 3. 
Sera from patients with mucosal PV fa il to induce disease in 
the neonatal mouse model lgG from ·1 0 PV sera , including fo ur 
sera fi·o m patients w ith mucosa l PV and seven fi·om pati ents ·w ith 
generali zed disease , w ere p m ifi ed 3nd tested in th e n eonatal m o use 
m o del system. Three o f fo ur o f th e se ra fro m pati ..: nts w ith mu cosal 
PV were un3ble to induce disease in n eonata l mi ce (Pati e nts 1-3), 
despite PV au toantibody tite rs ;:;. j :320 in the m o use sera (Table 1). 
B io psies o f th e to ngue and buccal mucosa o f rhc mice also fitil ed to 
dem o nstrate any inflammatio n o r ac3ntho lys is. O ne pati ent w ith 
mucosa l di sease (P3ti en t 4) was no t tested du e to the limi ted am o u n t 
Two of th ese ser:1 ( 16, 18) were previo usly reponed (Anhalt t.'/ a/, \91)2) :lll cl WC I'l" nor rcrcsrcd. 
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Figure 2 . PV sera immunoprec1p1tate recombinant Dsg 3. All 19 PV 
sera in1n1unopreci p i t~ tcd the rcco1nbinant baculov irus-exprcsscd pro tein . N o ne 
of the control sera immunoprcc ipi ta ted the rDsg 3 prorein. 
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Figure 3. IP characterization of the antibody specificit)• in a patient 
whose clinical disease evolved from mucosal to generalized PV. Utilizing 
the 45-kDa fragn1 ent of bovine Dsg I for I P studies. nonnal hu111 an serum in 
lfl nc I se rved as a negative comrol, whereas lane 2 is a p sitivc control using 
seru111 fro 111 a pat ient with fogo se lvage n1. T he initial serum ample from 
the paricm when her disease was restricted to the or:d nHJ cosa did nor 
itlllnunopJ-ec ipitatc Dsg I (la ne 3). A sample obta ined when her disease 
generali zed to the gbbrous skin (/m1c .J) i111Jnut1oprec ipi ta tcd the 45-kDa Dsg 
I fi·~1 gme nt . 
of serum ava ilable. Th ·· lgG lio m all seven pati ents w ith genera lized 
disease indu ced suprabas ilar acanth olys is in th e mo use model. 
O n set of gen eralized d isease cor respond s to d evelopm en t of 
anti- Dsg 1 a u toan tib o dies Interestin gly, we had th e opportunity 
to fo ll ow an unusual patient (Patient 5) w ith mu cosa.! PV w hose lgG 
w as path ogenic in the mo use m odel , that subsequ ently developed 
extensive bliste rs and erosions in vol ving th e glabro us skin . A repeat 
skin bi opsy showed supra basilar acantho lys is in th e epidermis and direct 
IF was positi ve, producing an inrercell ubr space pattern of stainin g 
(data no t shown). Serum o btained at the rime o f th e o nset of th e 
cutaneo us disease recogni zed th e bo vine 45 kDa immun oreactive 
fi·agmenr by J P techniques (F ig 3). In contrast, a serum sa mple obtain ed 
severa l months before at th e tim e the patient had only o ral disease, 
reacted only with Dsg 3 . 
D ISCUSS IO N 
All of th e PV patients demo n ·trated an intercellular spa ce patte rn o n 
direct and indirect I F. The subclass specifi city of th e circulating 
autoa ntibodies in o ur group was similar to that previo usly reported by 
j o nes c/ a/ ( 1988). All 19 patients had a predominant lgG4 autoantibody 
response . A small er number also had lgG 1, IgG 2, o r IgG 3 subclass 
antibodies; however, th e titers of th ese antibodi es were mu ch lower 
than those of IgG 4. Wh en th e circulating autoa11tibodies were tested 
on va rio us substrates, the pati ents bega n t sorr into two gro ups based 
on th e loca lization o f their disease . Sera fro m patiems w ith mucosal 
PV showed hi gher indirect IF titers o n human mu cosa than o n human 
skin . PV patients w ith 1nucosal disease also had wea k o r no reacti vity 
with mo use skin by indirect IF, and only o ne patient in thi s gro up 
produced d isease in the neonatal m o use model. 
A common clnracte•·isti c o f all the PV sera tested was the ability to 
immun oprecipitate th e recombinant ex tracellu lar do main o f I sg 3, 
sugges ting that rel evant confo rmatio nal epitopes are expressed in this 
do main. The epiropes recognized by man y PV sera are likely to be 
conformati o nal and are des troyed by the denaturatio n o f wes tern 
blo tting, as o nly l l of 19 (57'){,) were positive w ith this tec hnique. 
Th e :1bi lity to produ ce disease in the m ouse model did no t correlate 
w ith th e prese nce o r absen ce o f nonconfo nnatio nal epito pes as detected 
by blotting. 
Interestin gly, three o f to ur of rhe pati ents w ith mucosal PV that 
were tes ted in th e neonata l mo use model f.1ikd to induce skin o r mucosal 
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lesio ns, sugges tin g that the epitopes respo nsible fo r developm ent of 
mucosaJJes io ns are human specific. Th e o ne mucosal PV patient w ho 
induced disease in the mouse model also had equivalent indirect IF 
titers in sk.in and bu ccal mu cosa, and shortly after our resting wenr o n 
to develop skin k sio ns and Dsg 1 cross-reactivi ty. In contrast, all 
patients ' ith generali zed disease were capable of produ cing disease in 
the mo use model, even w hen by IF they had lo w level of reactivity 
w ith mouse skin (Pati ent 17) . 
13en veen 25 and 60% of PV patien rs' sera cross-react w ith Dsg 1 
depending o n th e techniques utiLized (Eyre and Stanley, 1987; H ashim-
oto cr a/, 1990; Dmochow k.i el a/ , 1992; O lague-Alcala el a/, 1994; 
Emery er n/, 1995) . T he overall sequ ence similari ty / identi ty between 
D sg 3 and .I sg 1 is 64%/46%. w hich may explain this high level of 
ross- reacti vity. When PV sera were exa mined fo r cross- reac tivity with 
D sg I, the mu osa l group showed striking di ffe rences from patients 
w ith generali zed disease . N one of the fi ve sera fi·om patient with 
disease restri cted to the mu cosae showed cross-reactivity with D sg 1. 
In contrast J 0 of 1-t se ra fi·om patients with generali zed disease reacted 
with Dsg I. T he path ogeni c relevance o f anri-Dsg 1 autoantibodies in 
PV pati ents is unkn own; however, endemic PF autoantibodi es bind co 
o d mucosa bur do no t induce lesions, suggesting that ami- D sg 1 
autoantibodi es are m ore relevant to cutaneous than mu cosa l disease 
(R.i virti er nl, 1994). 
It has been hypo thesized in :1uto im.mune diseases that the initial 
response is directed aga inst a specifi c epitope in the target anti gen, and 
that over tim e there is spread of th e T- and B-cdl response to o ther 
epi topes within th e target protein :md then to o ther antigens at th e 
site of inA~mmation. T his h~s been te rmed "determinant spreading" 
o r "epitope spreading" (Kaufimn , 1993) . D evelopm ent of anti-Dsg 1 
autoantibodi es in PV pati ems may be a manifestation of determinant 
spreading. O ur data suggest that in many pati ents th e o riginal response 
is directed aga inst an epi tope o n Dsg 3 that is mo re accessible in 
mu cosal ti ssue and that over time th e immune respo nse spreads to 
o ther epitopes in Dsg 3 that induce skin lesions and cross-react w ith 
Dsg I . Alte rnative ly, th e response may spread to D sg 1 because of its 
loca ti o n nea r th e site of infl:1mmatio n. 
lntercsting.ly, during the course of our studies o ne PV patient w ith 
mu cosal disease suddenly developed a large number of cutaneous 
bliste r <111d erosio ns. This was also th e only mucosal patient that could 
c:lUse disease in the mo use model. S ··rum obtain ed at th e time o f the 
onse t o f th e cutaneous lesions show ed new spe ifi city, i.e., aga inst D sg 
I. Pati ents have previously been described w ho have co nverted .from 
PV to PF (H ashimoto £'1 nl, 199 1; Iwa tsuk.i el nl, 199 '1; Kawana er nl, 
1994); however, our pa1:ienr continu es to have mucosal as w ell as 
cutaneous disease and histo logic findin gs of PV rath er than PF. 
Th ese findin gs dem o nstr:lte that th e antigeni c specificity of a patient's 
autoa nribodies may change during th e course of the disease. and that 
this n1ay correlate w ith th e appearance o f skin disease. O ur studies also 
sugges t th at th e population of autoantibodies that induce disease in 
mu cosa have a difle rent specificity than those that induce disease in 
gbbro us skin and that antibodies that produce disease in th e skin are 
mo re likely to cross- react with Dsg "J . This heterogeneity in the PV 
autoantibodi es and / or antigens may play a ro le in modulating r.h e 
differential expressio n of th e disease in th e skin and o ral mu cosa. 
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